Omid Seidizadeh: Honored to Join NordCoag 2026 to Celebrate 100 Years of von Willebrand Disease
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, reposted from NordCoag 2026 on LinkedIn:
”Thank you to the NordCoag 2026 organizers for the invitation.
Honored to speak in this special session marking 100 years since the first description of von Willebrand disease and to discuss advances linking pathophysiology, diagnostics, and patient management.
Looking forward to meeting colleagues and friends in Stockholm, 18 September, 2026.”
Quoting NordCoag 2026‘s post:
”One hundred years after von Willebrand disease was first described, there is still much to explore!
NordCoag 2026 final session is dedicated von Willebrand disease and will feature invited speaker Omid Seidizadeh (Milano, Italy) speaking on von Willebrand Disease: Linking Pathophysiology, Diagnostics, and Patient Management.
The session also includes colleagues from Karolinska University Hospital with August Lundholm on Insights from Approximately 300 von Willebrand Disease Genetic Investigations, and Anna Ågren on Acquired von Willebrand’s Disease.
Discover the full scientific programme at NordCoag 2026 website and sign up today. Welcome!”
Stay updated with Hemostasis Today.
-
Aug 16, 2026, 13:53Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
-
Aug 16, 2026, 13:46Sagar Bejalwar: A Rare Bleeding Disorder and the Importance of Specialized Care
-
Aug 16, 2026, 13:39Sharun Khan: Advancing Regenerative Medicine Through Veterinary Translational Science
-
Aug 16, 2026, 13:21Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
-
Aug 16, 2026, 13:05Neil Morgan: Submit Your Abstract for BSHT 2027
-
Aug 16, 2026, 12:50Heba Youssef: Can Cefoperazone Cause Coagulopathy?
-
Aug 16, 2026, 12:35Mohammad Alkhalil: Stroke Remains a Dreaded Complication in TAVI
-
Aug 16, 2026, 12:16Jeff Schaffnit: The Power of Community in Rare Blood Disorders
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?